46,459views
00:00 / 00:00
of complete
of complete
2024
2023
2022
2021
S4 heart sound and p. 731
Cardiomyopathy translates to “heart muscle disease,” so cardiomyopathy is a broad term used to describe a variety of issues that result from disease of the myocardium, or heart muscle.
When cardiomyopathy develops as a way to compensate for some other underlying disease like hypertension or valve diseases, it’s called secondary cardiomyopathy, but when it develops all by itself it’s called a primary cardiomyopathy.
Restrictive cardiomyopathy is where the heart muscle is restricted, meaning it becomes stiffer and less compliant. The muscles and size of the ventricles, though, stay about the same or maybe they only get slightly enlarged.
Normally, when blood fills the ventricles, they’re compliant so they stretch out and allow more blood to fill in. When blood fills into restricted ventricles, though, they aren’t allowed to expand. So stiffer, less compliant ventricles means that the ventricles can’t stretch, and less blood fills into the ventricle, which means the heart’s starts to fail to pump out enough blood to the body. So restrictive cardiomyopathy causes heart failure, and since filling happens during diastole, we say this is a type of diastolic heart failure.
Now several mechanisms can lead to stiffer heart muscles and restrictive cardiomyopathies. One of these is amyloidosis. Amyloids are proteins that have been misfolded, and once misfolded they become insoluble and can deposit in various tissues and organs, making them less compliant.
Familial amyloid cardiomyopathy is a genetic disorder where mutant transthyretin protein, or TTR, is misfolded and prone to depositing in the heart tissue. TTR’s a protein that usually circulates in the blood and helps transport thryoxine and retinol. And mutations in TTR are more common in African Americans. Similarly, senile cardiac amyloidosis is where, over time, wild-type, or normal TTR deposits in the heart, and this is typically seen in the elderly.
Restrictive cardiomyopathy is a form of cardiac disease in which the ventricles are too stiff to relax and contract adequately. This leads to a decrease in the amount of blood pumped to body tissues, which fails to meet metabolic demands. Restrictive cardiomyopathy can present with signs of congestive heart failure, which include dyspnea, fatigue, swelling of the legs and abdomen, chest pain, and low urine output.
Major causes of restrictive cardiomyopathy include sarcoidosis, which involves the formation of granulomas in the heart tissue; amyloidosis, in which misfolded proteins called amyloids deposit in various organs including the heart making them less compliant; and hemochromatosis that's characterized by an excessive iron deposit in the heart tissue, which results in the impaired ventricular filling. There is also endocardial fibroelastosis, which happens when fibrosis develops in the endocardium; and finally, Loeffler's endocarditis, which happens when eosinophils accumulate in the heart tissue. Treatment for restrictive cardiomyopathy is generally aimed at managing symptoms and includes medications such as diuretics, which can help to reduce fluid buildup in the body. In some cases, a heart transplant may be necessary.
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.